Dacomitinib versus erlotinib in patients with advanced-stage, previously treated non-small-cell lung cancer (ARCHER 1009): a randomised, double-blind, phase 3 trial.
暂无分享，去创建一个
P. Jänne | K. O'Byrne | T. Mok | S. Ramalingam | J. von Pawel | L. Paz-Ares | I. Taylor | A. Płużański | M. Boyer | J. Bennouna | L. I. Docampo | Hui Zhang | J. O'Connell | Z. Goldberg | C. B. Mather | M. Shtivelband | Jane Q. Liang | J. Doherty